MACK shareholders approve dissolution—cash distribution=$15.10/sh: https://www.businesswire.com/news/home/20240510857372/en The liquidating distribution stems from a $225M milestone payment MACK received from Ipsen for FDA approval of Onivyde (#msg-173845049). MACK had been a shell company with a contingent receivable since ceasing operations almost five years ago (#msg-149704592).